TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Pacific Biosciences of California (PACB)

Healthcare Medical Devices
1.40 $
+1.4% vs. previous close
Closing price · As of: 3. Aug 2026

Pacific Biosciences of California (PACB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 782 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet PACB
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
1,848 1,898 1,746 1,670 1,509 1,450 1,260 861 825 803 784 782
936 882 742 677 628 584 496 445 413 394 375 370
209 386 180 77 100 78 55 59 55 56 64 56
830 768 632 562 510 471 390 343 315 299 280 276
24 30 37 30 32 29 28 32 32 31 35 29
68 68 57 67 69 66 59 54 54 53 49 51
40 – – – – – – – – – – –
410 464 462 462 369 369 318 318 318 318 318 318
410 462 457 450 443 436 390 18 17 16 15 14
1,206 1,135 1,045 1,021 1,017 997 754 769 764 767 779 780
271 184 95 73 78 60 66 67 60 63 54 65
9.2 9.5 10 9.8 12 11 10 2.4 0.7 3.6 0.4 0.3
17 16 15 21 17 12 17 14 15 16 21 14
892 892 892 893 893 893 647 646 646 645 645 644
642 764 701 649 493 453 507 92 61 36 5.3 2.4
-1,690 -1,757 -1,839 -1,917 -2,091 -2,151 -2,149 -2,575 -2,617 -2,655 -2,695 -2,704
250 255 267 270 272 273 307 297 300 301 302 306

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?